Pemphigus: Current therapy

Veterinary Dermatology

Volumn 15, Issue 2, 2004, Pages 90-98

  Rosenkrantz, Wayne S ^a,b  

^a Animal Dermatology Clinic   (United States)

^b NONE   (United States)

Author keywords

Azathioprine; Chlorambucil; Chrysotherapy; Cyclosporin; Dapsone; Glucocorticoids; Mycophenolate mofetil; Pemphigus; Tacrolimus; Tetracycline and niacinamide

Indexed keywords

AMCINONIDE; ATOPICA; AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; CHLORAMBUCIL; CORTICALM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; DEXAMETHASONE; FLUOCINONIDE; GENESIS; GLUCOCORTICOID; GOLD; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISOLONE SODIUM SUCCINATE; SALAZOSULFAPYRIDINE; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; TSUKUBAENOLIDE;

BLOOD ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG ACTIVITY; DRUG EFFECT; ERYTHEMATOUS PEMPHIGUS; GOLD THERAPY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PANEPIDERMAL PUSTULAR PEMPHIGUS; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REVIEW; TOXICITY;

ANIMALS; ANTIRHEUMATIC AGENTS; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DAPSONE; DOG DISEASES; DOGS; GLUCOCORTICOIDS; IMMUNOGLOBULINS, INTRAVENOUS; MYCOPHENOLIC ACID; NIACINAMIDE; ORGANOGOLD COMPOUNDS; PEMPHIGUS; SULFASALAZINE; TACROLIMUS; TETRACYCLINE;

PEMPHIGUS;

EID: 1842633764     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2004.00360.x     Document Type: Review

References (46)

1. Suter, M.M., Bruin, A., Wyder, M. et al. Autoimmune diseases of domestic animals; an update. In: Kwochka, K.K., ed. Advances in Veterinary Dermatology III. Boston: Butterworth-Heinemann, 1998: 321-37.
2. Robinson, N.D., Hashimoto, T., Amagai, M. et al. The new pemphigus variants. Journal of the American Academy of Dermatology 1999; 40: 649-71.
3. Suter, M.M., De Bruin, A., Wurm, S. et al. Bullous autoimmune skin diseases in animals. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1997; 100-3.
4. Rosenkrantz, W.S. Pemphigus foliaceus. In: Griffin, C.E., Kwochka, K.W., MacDonald, J.M., eds. Current Veterinary Dermatology. St. Louis, MO: Mosby, 1993: 141-8.
5. Carlotti, D.N. et al. Pemphigus vulgaris in the dog. A report of 8 cases. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1999; 15-21.
6. Wurm, S., Mattise, A.W., Dunstan, R.W. Comparative pathology of pemphigus in dogs and humans. Clinical Dermatology 1994; 12: 515-24.
7. Walder, E.J. Werner, A. A possible paraneoplastic skin disease with features of erythema multiforme and pemphigus foliaceus in a dog. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1996: 70.
8. Scott, D.W., Miller, W.H., Griffin, C.E. Small Animal Dermatology, 6th edn. Philadelphia: WB. Saunders, 2001: 678-93.
9. Dugan, E.M., Anhalt, G., Diaz, L.A. Pemphigus. In: Jordan, R.E., ed. Immunologic Diseases of the Skin. Norwalk, CT: Appleton and Lange, 1991: 279-91.
10. Stanley, J.R. Pemphigus. In: Freedberg, I.M., Eisen, A.Z., Wolff, K. et al. eds. Fitzpatrick's Dermatology in General Medicine V. New York: McGraw-Hill, 1999: 654-65.
11. Lombardi, C., Borges, P.C., Chaul, A. et al. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). Journal of Investigations Dermatology 1992; 18: 847-50.
12. Ruocco, V., Brenner, S., Ruocco, E. Pemphigus and diet: does a link exist? International Journal of Dermatology, 2001; 40: 161-3.
13. Griffin, C.E. Pemphigus foliaceus: recent findings on the pathophysiology and results of treatment. Presentation, William Dick Bicentenary, Edinburgh, 1993.
14. Iwasaki, T., Maeda, Y. The effect of ultraviolet (UV) on the severity of canine pemphigus erythematosus. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1997: 86.
15. Reis, V.M.S. UVB-induced acantholysis in endemic pemphigus foliaceous (fogo selvagem) and pemphigus vulargis. Journal of the American Academy of Dermatology 2000; 42: 571-6.
16. Iwasaki, T., Shimizu, M., Obata, H. The detection of the autoantigen targeted by patient sera from dogs with pemphigus foliaceus. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1996: 44.
17. Amagai, M., Ishii, K., Hashimoto, T. et al. Conformational epitopes of pemphigus antigens (Ssg1 and Dsg3) are calcium dependent and glycosylation independent. Journal of Investigative Dermatology 1995; 105: 234-47.
18. Crameri, F.M., Suter, M.M. Induction of acantholysis in a serum-free culture system. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 1994: 63.
19. Suter, M.M., Ziegra, C.J., Cayatte, S.M. et al. Identification of canine pemphigus antigens. In: Ihrke, P.J., Mason, I.S., White, S.D., eds. Advances in Veterinary Dermatology. Oxford: Pergamon Press, 1993: 367-80.
20. Kawana, S., Geoghegan, W.D., Jordon, R.E. Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. Journal of Investigative Dermatology 1986; 86: 29-33.
21. Scott, D.W., Walton, D.K., Slater, M.R. et al. Immune-mediated dermatoses in domestic animals ten years after - Part I. Compendium of Continuing Education for the Practicing Veterinarian 1987; 9: 424-35.
22. Gomez, S.M., Morris, D.O., Goldschmidt, M.H. Factors affecting mortality or survival in dogs with pemphigus foliaceus. A retrospective analysis of 43 dogs. Proceedings of the Annual Members' Meeting of the Academy for Veterinary Dermatology and the American College of Veterinary Dermatologists 2002: 34.
23. Moriello, K.A., Fehrer-Sawyer, S.L., Meyer, D.J. et al. Adrenocortical suppression associated with topical otic administration of glucocorticoids in dogs. Journal of the American Veterinary Medical Association 1988; 193: 329-31.
24. Verheijen, F., Coert, A., Deckers, G.H. Adrenocortical suppression in dogs and rats after topical administration of betamethasone-17-valerate and resocortol butyrate. In: Kwochka, K.K., ed. Advances in Veterinary Dermatology III. Boston: Butterworth-Heinemann, 1998: 481-2.
25. Scott, D.W. Rational use of glucocorticoids in dermatology. In: Bonagura, J., ed. Kirk's Current Veterinary Therapy XII. Philadelphia: WB. Saunders, 1995: 573-81.
26. Werth, V.P., Lazarus, G.S. Systemic glucocorticoids. In: Freedberg, I.M., Eisen, A.Z., Wolff, K. et al., eds. Fitzpatrick's Dermatology in General Medicine V. New York: McGraw-Hill, 1999: 2783-9.
27. Rosenkrantz, WS. Immunomodulating drugs in dermatology. In: Kirk, R.W, ed. Current Veterinary Therapy X. Philadelphia: WB. Saunders, 1989: 570-7.
28. White, S.D., Rosychuk, R.A., Reinke, S.I. et al. Use of tetracycline and niacinamide for the treatment of autoimmune skin disease in 20 dogs. Journal of the American Veterinary Medical Association 1992; 200: 1497-500.
29. Berk, M.A., Lorincz, A.L. The treatment of bullous pemphigoid with tetracycline and niacinamide. Archives of Dermatology 1986; 122: 670-4.
30. Stahelin, H.F. The history of cyclosporine A (Saundimmune) revisited: another point of view. Experientia 1996; 52: 5-13.
31. Morris, R. Modes of action of FK506, cyclosporine A and rapamycin. Transplant Proceedings 1994; 26: 3272-5.
32. Kahan, B.D. Role of cyclosporine. Present and future. Transplant Proceedings 1994; 26: 3082-7.
33. Schreiber, S.L., Crabtee, G.R. The mechanism of action of cyclosporine A and FK506. Immunology Today 1992; 13: 136-42.
34. Rosenkrantz, WS., Griffin, C.E., Barr, R.J. Clinical evaluation of cyclosporine in animal models with cutaneous immune-mediated disease and epitheliotrophic lymphoma. Journal of the American Animal Hospital Association 1989; 25: 377-84.
35. Griffies, J.D., Mendelsohn, C.L., Rosenkrantz, W.S. et al. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus, Journal of the American Animal Hospital Association 2004; 40: 29-41.
36. White, J.V., Davis, W.R., Nachreiner, R. et al. Cyclosporine pharmacokinetics in normal and pancreatectomized dogs. Transplantation 1986; 24: 390-5.
37. Kelly, P.A., Burckart, G.J., Venkataramanan, R. Tacrolimus: a new immunosuppressive agent. American Journal of Health - Systematic Pharmacology 1995; 52: 1521-35.
38. Fujisawa, T., Saitoh, Y., Urabe, N. et al. Dose study of the immunosuppression of FK506 in canine lung allotransplantation. Japanese Journal of Surgery 1993; 23: 338-43.
39. Byrne, K., Morris, D.O. Study to determine the usefulness of Mycophenolate mofetil (MMF) for the treatment of pemphigus foliaceus in the dog. Proceedings of the 16th Annual American Academy of Veterinary Dermatology and the American College of Veterinary Dermatology Meeting, 2001.
40. Katz, K.H., Marks, J.G., Helm, K.F. Pemphigus foliaceus successfully treated with Mycophenolate mofetil as a steroids-sparing agent. Journal of the American Academy of Dermatology 2000; 42: 514-15.
41. White, S. Oral gold therapy. Dermatology Dialogue 1986; 5: 2.
42. Kummel, B.A. Medical treatment of canine pemphigus-pemphigoid. In: Bonagura, J.D., ed. Kirk's Current Veterinary Therapy XII. Philadelphia: W.B. Saunders, 1995: 636-8.
43. Scott, D.W. Sulfones and sulfonamides in canine dermatology. In: Kirk, R.W., ed. Current Veterinary Therapy IX. Philadelphia: W.B. Saunders, 1980: 606-9.
44. Scott-Moncrieff, J.C., Reagan, W.J., Snyder, P.W. et al. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. Journal of the American Veterinary Medical Association 1997; 210: 1623-27.
45. Rutter, A., Luger, T.A. High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune disease of the skin. Journal of the American Academy of Dermatology 2001; 44: 1010-24.
46. Ahmed, A.R. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. Journal of the American Academy of Dermatology 2001; 45: 679-90.